Topic Follow by RSS
GLP-1 drugs
Class of injectable weight-loss and diabetes medications
Also: GLP-1, Ozempic, semaglutide, GLP-1 weight-loss drugs
In 61 articles · first seen · latest
Solid lines: relations reported in articles. Dashed: appear in the same stories. Thicker means more evidence.
Timeline
-
14 Nov 2026 · 1 outlet
Study links GLP-1 weight-loss drugs to higher heart attack, stroke risk in one group -
14 Nov 2026 · 1 outlet
Ozempic's effect on fashion industry's body-positivity stance -
14 Nov 2026 · 1 outlet
Hundreds of children in England prescribed GLP-1 weight-loss drugs, Guardian finds -
14 Nov 2026 · 1 outlet
Woman hospitalised after taking black market weight-loss jab sold as retatrutide -
13 Nov 2026 · 1 outlet
Millions in US use unapproved GLP-1 drugs or use them in unapproved ways, study finds -
9 Nov 2026 · 14 outlets
FDA requires GLP-1 drug labels to warn of rare eye condition NAION -
12 Nov 2026 · 2 outlets
Doctor lists six rebound risks after stopping GLP-1 weight-loss drugs -
12 Nov 2026 · 1 outlet
Evidence for microdosing GLP-1 drugs as antiaging treatment -
12 Nov 2026 · 1 outlet
Animal study finds semaglutide may reduce oxygen supply to fetuses in pregnant sheep -
12 Nov 2026 · 1 outlet
Analysis suggests middle-aged GLP-1 users face higher risk of serious complications -
11 Nov 2026 · 1 outlet
Reports of psychotic symptoms in some people after stopping GLP-1 drugs -
10 Nov 2026 · 1 outlet
Study links GLP-1 weight-loss drugs to possible effects on brain health and Alzheimer's -
10 Nov 2026 · 2 outlets
Access to Medicine report finds mixed pharma progress on drug access in poorer countries -
9 Nov 2026 · 2 outlets
Study links stopping GLP-1 drugs to higher heart attack, stroke and death risk in type 2 diabetes -
5 Nov 2026 · 1 outlet
Study links GLP-1 drugs to lower mortality than metformin in prediabetes -
4 Nov 2026 · 1 outlet
Study finds GLP-1 drugs linked to lower heart attack and stroke risk than metformin -
30 Oct 2026 · 1 outlet
Body positivity's legacy in the GLP-1 era -
30 Oct 2026 · 1 outlet
Doctor warns of vitamin deficiency risk for people taking GLP-1 drugs, metformin and PPIs -
28 Oct 2026 · 1 outlet
GLP-1 weight-loss pills versus injections compared, with warning on online pills -
28 Oct 2026 · 1 outlet
Report finds wide variation in weight-loss drug prescribing across Scottish health boards -
27 Oct 2026 · 1 outlet
Experts weigh risks of running marathons while taking GLP-1 weight-loss drugs -
26 Oct 2026 · 1 outlet
Research finds nutrient deficiencies among GLP-1 drug users -
27 Oct 2026 · 1 outlet
Survey: one in six Gen Z South Koreans used GLP-1 drugs in 2025 -
26 Oct 2026 · 1 outlet
ACOG issues new guidance on GLP-1 drug use during pregnancy -
17 Oct 2026 · 1 outlet
New research suggests GLP-1 drugs may reduce cocaine cravings -
14 Oct 2026 · 1 outlet
New trial to study GLP-1 drugs and criminal justice, jobs and housing outcomes -
11 Oct 2026 · 1 outlet
Drug companies say GLP-1 drugs may reverse biological ageing by two to three years -
10 Oct 2026 · 1 outlet
Lawsuits allege GLP-1 drugs cause serious harm; data on frequency scant -
5 Oct 2026 · 3 outlets
Study links GLP-1 weight-loss drugs to nail detachment and hair loss, authors say cause unproven -
7 Oct 2026 · 6 outlets
WHO issues first child obesity guidelines, favouring lifestyle support over drugs -
7 Oct 2026 · 1 outlet
Review finds people regain about a pound a month after stopping GLP-1s -
5 Oct 2026 · 2 outlets
Weight-loss drug research tipped for Nobel medicine prize as 2026 announcements begin -
3 Oct 2026 · 1 outlet
GLP-1 use in one demographic rose 24-fold from 2018 to 2025, data show -
1 Oct 2026 · 1 outlet
More new US mothers taking GLP-1 drugs, with limited data on breastfeeding safety -
30 Sep 2026 · 2 outlets
Expert warns rapid weight loss on GLP-1 drugs could starve the brain of energy and nutrients -
29 Sep 2026 · 1 outlet
NYC raises fine for improper disposal of used GLP-1 pens after sanitation worker injuries